Hungarian medical services provider, Euromedic, is planning to sell its dialysis care business to Fresenius Medical Care, Financial Times reports. The U.S. company has offered around €485 million for International Dialysis Centers. Euromedic has appointed Bank of America Merrill Lynch as exclusive financial adviser on the deal. The sale is part of Euromedic’s broader strategy to focus on diagnostics and cancer treatment.
Click here for the story from Financial Times.
Click here for additional coverage from The Wall Street Journal.